SCHEMBL1710487

SCHEMBL1710487

Cc1ccc(C(=O)NF)cc1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
LIPE Q05469 6/20 0.37
GLA P06280 1/20 0.36
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
CA9 Q16790 4/20 0.36
CXCR2 P25025 3/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 1/20 0.33
PLA2G1B P04054 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX12 P18054 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4786480 0.87 HDAC6 (0.39) HDAC1HDAC6GLACA1CA2
SCHEMBL16599330 0.83 TAS1R3 (0.43) NPSR1
SCHEMBL2214140 0.83 MAPK14 (0.43) CA1CA2CA9KMT2AALDH1A1
SCHEMBL397041 0.82 TSHR (0.41) CA1CA2CA9KMT2AMEN1
SCHEMBL14217297 0.82 CYP2A6 (0.38) CA1CA2CA9KMT2AMEN1
SCHEMBL3228174 0.82 CXCR2 (0.55) CA1CA2CA9CXCR2KMT2A
SCHEMBL2717824 0.81 L3MBTL1 (0.45) CA1CA2CA9KMT2AMEN1
SCHEMBL21911828 0.81 NPC1 (0.50) CA1CA2CA9CXCR2KMT2A
SCHEMBL380118 0.81 GLA (0.50) GLAKMT2AMEN1NPC1RAB9A
SCHEMBL16566639 0.81 THRB (0.51) CA1CA2CA9CXCR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344472-A1 ISOQUINOLINONE DERIVATIVES AstraZeneca AB (SE) 2011-07-20 EP disclosed
WO-2010039079-A1 ISOQUINOLINONE DERIVATIVES ASTRAZENECA AB (SE) 2010-04-08 WO disclosed